ID: ALA5284180

Max Phase: Preclinical

Molecular Formula: C16H13NO2

Molecular Weight: 251.28

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(O)c(/C=C2\C(=O)Nc3ccccc32)c1

Standard InChI:  InChI=1S/C16H13NO2/c1-10-6-7-15(18)11(8-10)9-13-12-4-2-3-5-14(12)17-16(13)19/h2-9,18H,1H3,(H,17,19)/b13-9-

Standard InChI Key:  RZWUXOPMSYAGHL-LCYFTJDESA-N

Associated Targets(Human)

Aldose reductase 1404 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 251.28Molecular Weight (Monoisotopic): 251.0946AlogP: 3.19#Rotatable Bonds: 1
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.51CX Basic pKa: CX LogP: 3.48CX LogD: 3.47
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.76Np Likeness Score: -0.28

References

1. Kaur M, Singh M, Chadha N, Silakari O..  (2016)  Oxindole: A chemical prism carrying plethora of therapeutic benefits.,  123  [PMID:27543880] [10.1016/j.ejmech.2016.08.011]

Source